CHANGEBLOCK
27.11.2023 11:32:27 CET | Business Wire | Press release
Changeblock, a global sustainability fintech company utilizing advanced data-systems and technologies to accelerate planet repair and protection activities through the generation and exchange trading of high-integrity environmental assets, such as carbon credits, today announced the appointment of Baroness Evans of Bowes Park, former leader of the UK House of Lords, as Senior Advisor, Policy & Ethics.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231123431705/en/
Baroness Natalie Evans of Bowes Park, former UK Cabinet Minister as Leader of the House of Lords and Senior Advisor, Policy and Ethics of Changeblock Limited. (Photo: Business Wire)
Trust and integrity are crucial for companies to monetize their planet repair and protect initiatives, and therefore crucial for credits to be adopted at the scale necessary towards achieving net-zero, Consequently, policy and ethics are major focus areas for Changeblock that require integration into the credit value chain. The appointment of Baroness Evans will significantly strengthen the Company’s efforts in this regard, and augments the work already being done with multiple standard and verification agencies.
Baroness Evans commented, “Reducing society’s environmental footprint is one of the most pressing challenges we as humanity are facing today, and tradeable offsets, such as credits, hold great promise towards delivering this. Their effectiveness will be impacted by how the companies in this eco-system engage with policy and policy makers.
“Ethics play an increasingly important role in credit integrity assessments and in investment decision making. Changeblock’s forward, strategic thinking, combined with their unique offering that meets such a critical need, make this an exciting opportunity. I look forward to working with Billy and the team and help Changeblock cement its leadership position as a critical net-zero infrastructure partner.”
Billy Richards, Changeblock CEO, stated, “We believe Baroness Evans is exceptionally well positioned to provide Changeblock with actionable insights, and help us strengthen our position as a critical infrastructure partner for credit generators, off-setters, investors and policy makers. I believe this appointment reflects the importance, integrity and quality of our offering, as well as the depth and strength of our network, and I am excited to be working on these important initiatives with Natalie as we expand our operations and help smooth the path to net-zero.”
Baroness Evans
Baroness Evans of Bowes Park is a Conservative member of the House of Lords. She was appointed a life peer in October 2014, and acted as Leader of the House of Lords and a member of the UK Government’s Cabinet from 2016 to 2022 - the longest serving Leader for 70 years. Between 2015 and 2016 she was a junior Government minister in the Department of Education, Department for Work and Pensions, and the Ministry of Justice. Before entering the Lords, Natalie held a variety of senior positions including CEO of the New Schools Network, Deputy Director of Policy Exchange, and Head of Policy at the British Chambers of Commerce.
Changeblock at COP28
Billy Richards and Baroness Natalie Evans from Changeblock will attend COP28 in Dubai. Changeblock is hosting a roundtable with leaders like David Greenall (KPMG), Jim Andrew (Pepsico), and Michael Terrell (Google), discussing AI analytics in carbon offsetting. The roundtable, titled “The Critical Role of Integrity in Carbon Credits and Offsets for Effective Planet Repair,” will explore sustainable carbon mitigation strategies.
About Changeblock
Changeblock creates global markets that make the creation and trade of environmental assets for individuals, businesses, and governments easy, affordable, transparent, secure, and environmentally responsible. The company is led by professionals with deep expertise in technology and environmental credits with a proven track record in building and delivering solutions that work in the real world, including members of the team that created the first carbon credit, and come from top global organisations.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231123431705/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Duco Launches the First Agentic Operations Platform for Financial Services27.5.2026 09:20:00 CEST | Press release
Duco, today launched the first agentic Operations platform for financial services. Built on the engine that already processes 20 billion transactions every month for more than 200 clients, including seven of the top 20 banks and ten of the top 20 asset managers, the platform brings together everything firms need to run post-trade Operations alongside autonomous agents, safely and at scale. The launch establishes a breakthrough the industry has been waiting for. A tool surface, purpose-built for agents. Duco has unbundled its platform into a new alternative agent layer that reconfigures its platform into hundreds of discrete capabilities servicing post trade. Model Context Protocol (MCP) gives capabilities covering reconciliation, data preparation, data access, audit trails, exception management, document creation and more. For the first time, agents have a verified, deterministic toolset built specifically for post-trade. Agents do not replace matching, rules or audit; they use them. P
Brenus Pharma Announces FDA Acceptance of IND Application for STC-1010 (BreAK-CRC001) in MSS Metastatic Colorectal Cancer (mCRC)27.5.2026 08:49:00 CEST | Press release
STC-1010 is a first-in-class allogeneic in vivo immunotherapy for which the FDA has authorized clinical evaluation in the U.S. under the BreAK-CRC001 study. This strategic milestone enables the company to execute a global clinical strategy following European regulatory approvals (ANSM, AFMPS), first patients dosed with preliminary results and good tolerability observed in early Phase Ia. First data are expected to be presented during ESMO annual congress 2026. Brenus Pharma, a clinical stage biotechnology company developing novel in vivo immunotherapies for solid tumors, announced that the U.S. Food and Drug Administration (FDA) has accept the company's Investigational New Drug (IND) application for its first drug candidate, STC-1010, in microsatellite stable (MSS) metastatic colorectal cancer (mCRC). STC-1010 is designed to address a critical unmet need worldwide. Approximately 95% of mCRC patients have MSS tumors, which demonstrate minimal response to standard immunotherapies. The FD
Tide Crosses 2 Million Members Worldwide - Big Step Forward in Mission to Support and Grow Small Businesses27.5.2026 08:00:00 CEST | Press release
Continuing to grow in the UK and internationally, with India seeing especially strong member growth in the last 12 months In the UK, Tide has 15% market share and has helped small businesses access over £1.75bn in credit Rapid roll out of products; from admin, accounting and tax tools; subscription options; payment solutions; government registrations; bill payments and credit Tide, the UK’s leading business management platform, today announces it has crossed 2 million members globally, with India in particular seeing strong growth. More than 1.1 million small businesses joined Tide in India since the company launched there in December 2022. This makes India Tide’s fastest-growing market by member acquisition. The UK is Tide’s home market, with 900,000 SMEs, 15% market share, and the majority of the company’s revenue. Tide’s steadily expanding its presence in Europe, with Germany and France, where the platform is gaining strong traction, thanks to millions of small businesses turning to
Alfasigma presents first data on filgotinib from the Phase 3 OLINGUITO trial in axial spondyloarthritis at EULAR 202627.5.2026 08:00:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific and investor media only.In the OLINGUITO Phase 3 study in radiographic (r) and non-radiographic (nr) axial spondyloarthritis (axSpA) a significantly greater proportion of patients achieved the prespecified primary endpoint of ASAS40 with filgotinib compared with placebo at week 16.The improvements in signs and symptoms of axSpA with filgotinib, an oral, once-daily JAK1 preferential inhibitor, were observed as early as week 1 and maintained over 52 weeks of treatment.In the r-axSpA and nr-axSpA filgotinib groups, of those achieving a response in the prespecified primary endpoint of ASAS40 at week 16, 84.6% and 78.0% maintained their responses to week 52, respectively.In OLINGUITO no new safety signals were observedfor filgotinib over 52 weeks, and the safety profile was consistent with the known overall safety profile.Primary results from the Phase 3 OLINGUITO tria
Royal London Asset Management Expands Relationship with SS&C to Service New Australian Funds27.5.2026 00:00:00 CEST | Press release
SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced that Royal London Asset Management, a leading U.K. fund management company, has extended its relationship with SS&C. SS&C Global Investor & Distribution Solutions will provide fund administration and unit registry services for its new range of Australian active funds, including: Royal London Global Equity Diversified Fund Royal London Global Equity Enhanced Fund Royal London Global Equity Select Fund Royal London Short Duration Global High Yield Bond Fund RLAM is part of Royal London, the U.K.’s largest mutual life, pensions and investment company. SS&C services approximately £72bn in assets under management across its U.K. fund range. Equity Trustees will serve as the Responsible Entity for RLAM’s new funds, which have launched with around AUD $1 billion in AUM. The unit trusts are structured as feeder funds, providing investors with indirect exposure to RLAM’s range of Dublin-domiciled Undertakings for Collective Investm
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom